XML 88 R77.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 29, 2022
Apr. 30, 2021
Apr. 29, 2022
Apr. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,249,478 $ 1,149,107 $ 2,182,128 $ 2,022,093
Cost of Sales (844,109) (746,154) (1,476,283) (1,304,104)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 24 (4,185) (245) (6,183)
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,249,478 1,149,107 2,182,128 2,022,093
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (844,109) (746,154) (1,476,283) (1,304,104)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings (91) (4,115) (209) (6,212)
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value (650) 300 (1,576) 462
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 115 (70) (36) 29
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 456 $ 111 $ 553 $ 296